TRANSCEND-HF - Clinical Trial

¿Cuál es el Propósito de este estudio?

In this study, you will have three devices used on the outside of your body to measure how your heart is working, your blood pressure, and the pressure inside your heart. During your procedure, a thin tube will also be placed into a vein in your heart called the coronary sinus. It will be gently moved into the lower part of your heart to take measurements. Your heart will then be paced, and the measurements will be taken again. These extra steps will add about twenty minutes to your procedure.

¿Cuál es la Condición que se está estudiando?

Patients undergoing implant of a cardiac resynchronization therapy device (CRT)

¿Quién puede participar en el Estudio?

People can join this study if they are 18 years or older and are getting a left sided dual chamber or CRT heart device as part of their normal medical care.

Grupo etario
Adultos

¿Qué Implica?

This study wants to learn how a special kind of pacing, called transvenous diaphragmatic pacing, affects blood flow in the body. This pacing gently moves the left half of the diaphragm, which is the muscle that helps you breathe. Researchers want to see if this type of pacing can help the heart work as well as the regular kind of pacing that stimulates the left side of the heart.

Detalles del Estudio

Título Completo
TRANSvENous Diaphragmatic Pacing for Heart Failure:(TRANSCEND-HF)
Investigador Principal
Daniel J. Friedman, MD
Especialista en electrofisiología
Número de Protocolo
IRB: PRO00117436
NCT: NA
Fase
Fase N/A
ClinicalTrials.gov
Estado de inscripción
Abierto para inscripción
Apoye la investigación de Duke Health o rinda homenaje a un ser querido con un regalo conmemorativo.
Contribuya a Duke Health